DGCI Nods for Emergency Use of Corbevax, Covovax COVID-19 Vaccines Amid Omicron Scare

Amidst the rising number of COVID-19 cases, the Drugs Controller General of India (DGCI) has approved two new COVID-19 vaccines – Corbevax and Covovax – for restricted use in India in an emergency situation, the Union Health Ministry announced on Tuesday. The drug regulator has also permitted the emergency use of the anti-viral drug Molnupiravir to treat adult coronavirus patients with a higher risk of disease progression.

Read More

Policybazaar exclusive benefits
  • 30 minutes claim support*(In 120+ cities)
  • Relationship manager For every customer
  • 24*7 claims assistance In 30 mins. guaranteed*
  • Instant policy issuance No medical tests*

*All savings are provided by the insurer as per the IRDAI approved insurance plan. Standard T&C Apply

*Tax benefit is subject to changes in tax laws. Standard T&C Apply

Find affordable plans with up to 25% Discount**
  • 1
  • 2
  • 3
  • 4

Who would you like to insure?

  • Previous step
    By clicking on “Continue”, you agree to our Privacy Policy and Terms of use
    Previous step

      Popular Cities

      Previous step
      Previous step

      Do you have an existing illness or medical history?

      This helps us find plans that cover your condition and avoid claim rejection

      Get updates on WhatsApp

      Previous step

      When did you recover from Covid-19?

      Some plans are available only after a certain time

      Previous step
      Advantages of
      entering a valid number
      You save time, money and effort,
      Our experts will help you choose the right plan in less than 20 minutes & save you upto 80% on your premium

      Corbevax and Covovax COVID-19 Vaccines

      Corbevax is an indigenous RBD protein sub-unit vaccine for COVID-19 developed by Biological-E in Hyderabad. On the other hand, Covovax is a nanoparticle vaccine that will be manufactured by the Serum Institute of India (SII) in Pune.

      It is the second COVID-19 vaccine to be developed by SII after Covishield. While Corbevax will be administered in two doses of 0.5 ml each with a gap of 28 days, Covovax will be given 21 days apart. Both vaccines can be easily stored between a temperature of 2 to 8 degrees.

      With Corbevax and Covovax getting the nod, a total of eight COVID-19 vaccines have been authorized for use in India, including Covaxin, Covisield, Sputnik V, Moderna, ZyCoV-D and Johnson & Johnson.

      Molnupiravir Anti-viral Pill Against COVID-19

      The anti-viral drug Molnupiravir, developed by US-based companies Merck and Ridgeback, will be manufactured by 13 companies in India. As per the clinical trial results, the drug has reduced hospitalization and deaths due to COVID-19 by 30 per cent.

      The drug was first used to treat COVID-19 in Britain in November and has been recently allowed for treating mild-to-moderate coronavirus cases by the US Food and Drug Administration.

      Disclaimer: Policybazaar does not endorse, rate or recommend any particular insurer or insurance product offered by an insurer.

      Health insurance articles

      Recent Articles
      Popular Articles
      Does SBI Health Insurance Cover Dental Treatments?

      05 Jun 2024

      SBI General Insurance Company provides comprehensive coverage
      Read more
      Does ICICI Lombard Health Insurance Cover Dental Treatments?

      05 Jun 2024

      ICICI Lombard General Insurance Company offers various health
      Read more
      Does Reliance Health Insurance Cover Dental Treatments?

      04 Jun 2024

      Dental insurance is crucial in safeguarding oral health as it pays
      Read more
      Does HDFC ERGO Health Insurance Cover Dental Treatments?

      22 May 2024

      HDFC ERGO General Insurance Company offers various health
      Read more
      Does Aditya Birla Health Insurance Cover Dental Treatments?

      17 May 2024

      Dental insurance is vital in maintaining oral health by covering
      Read more
      How to Apply for Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (PM-JAY)?
      Ayushman Bharat Yojana is a flagship health insurance scheme launched by the Government of India to offer universal
      Read more
      Best Health Insurance Plans for Senior Citizens
      Senior citizens are the most prone to diseases. Considering the medical inflation in India, buying health insurance
      Read more
      10 New IRDAI Health Insurance Guidelines in 2024
      Health insurance penetration in India is far lower than it should be. A significant chunk of the Indian population
      Read more
      10 Major Benefits of Ayushman Bharat Yojana
      Pradhan Mantri Jan Arogya Yojana (PM-JAY) is the second component under Ayushman Bharat Scheme. PM Narendra Modi
      Read more
      Does Health Insurance Provide Coverage for LASIK Eye Surgery?
      A vast majority of the Indian population is suffering from vision problems. For some of them, LASIK eye surgery is
      Read more

      Download the Policybazaar app
      to manage all your insurance needs.